Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke.
Chongke ZhongGuangli WangTan XuZhengbao ZhuDaoxia GuoXiaowei ZhengAili WangXiaoqing BuHao PengJing ChenTian XuYanbo PengQunwei LiZhong JuDeqin GengJiang HeYonghong ZhangPublished in: Neurology (2019)
Higher TIMP-1 levels were associated with increased risk of mortality and major disability after acute ischemic stroke. Our findings provided evidence supporting the important prognostic role of extracellular matrix biomarkers after acute ischemic stroke.